钆塞酸增强磁共振成像肝胆期高信号肝脏病变:临床意义与价值
本文综述钆塞酸增强MRI肝胆期(注射后20分钟)表现为高信号的各类肝脏病变的临床意义、诊断价值与预后信息,包括高信号肝细胞癌、β-catenin突变肝细胞腺瘤、局灶性结节性增生及FNH样病变、结节性再生性增生、肝内胆管癌的云状强化及部分转移瘤等,强调识别高信号模式有助于准确诊断并提供预后与治疗生物标志物信息。
要点
- 钆塞酸增强MRI肝胆期于给药后20分钟采集,多数肝脏病灶因无肝细胞功能呈低信号,高信号为特征性表现。
- 高信号肝细胞癌恶性度较低、预后一般较好,但对免疫治疗(含抗程序性细胞死亡抑制剂)反应较差。
- β-catenin突变肝细胞腺瘤呈肝胆期高信号,其信号强度模式可区分外显子3突变相关的恶变潜能。
核心结论
- 肝胆期高信号是重要诊断要素和影像生物标志物,理解其信号模式有助于准确诊断并提供预后与治疗相关信息。
研究设计与样本
- 综述,围绕钆塞酸增强MRI肝胆期(给药后20分钟)高信号肝脏病变的临床意义、诊断价值与预后价值进行探讨。
关键影像表现/征象
- 高信号肝细胞癌表现为肝胆期高信号,恶性度较低、预后一般较好,但对包括抗程序性细胞死亡抑制剂在内的免疫治疗反应较差。
- 不均匀高信号肝细胞癌治疗结局较差。
- β-catenin突变肝细胞腺瘤呈肝胆期高信号,信号强度模式可区分外显子3突变相关的恶变潜能。
- 局灶性结节性增生(FNH)及FNH样病变呈肝胆期高信号,信号强度模式多样,可显著减少不必要的活检。
- 结节性再生性增生及再生性、多腺泡再生性结节在肝胆期呈高信号或环状高信号,但动脉期无强化。
诊断标准与关键数值
- 肝胆期成像于钆塞酸给药后20分钟进行。
- 肝内胆管癌的云状强化为关键鉴别诊断特征及不良预后指标。
- 结直肠、乳腺和胰腺腺癌肝转移偶含轻度高信号区,可能与不良预后或化疗反应较低相关。
- 富血供病变及相对较大的肿瘤可见瘤周高信号,但其临床意义尚未确立。
临床应用与阅片要点
- 阅片时需识别肝胆期高信号模式,以辅助准确诊断并提取预后与治疗生物标志物信息。
- FNH及FNH样病变的肝胆期高信号表现可显著减少不必要的活检。
- 肝内胆管癌的云状强化应作为关键鉴别诊断特征和不良预后指标加以报告。
- 结节性再生性增生等病变肝胆期呈高信号或环状高信号但动脉期无强化,需与其它高信号病变区分。
局限性
- 瘤周高信号的临床意义尚未确立。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Hepatobiliary (HB)-specific magnetic resonance imaging (MRI) contrast agents, particularly gadoxetic acid, are being increasingly utilized for liver imaging, with well-established clinical utility. The most distinctive feature of gadoxetic acid is HB phase imaging performed 20 min after administration. In clinical practice, most focal liver lesions lack gadoxetic acid uptake and appear hypointense against the background of normally enhancing liver parenchyma owing to the absence of hepatocyte function within the tumor tissue. Less commonly, various liver lesions show hyperintensity on HB phase imaging, which is a characteristic diagnostic feature. Hyperintense lesions in the HB phase are crucial diagnostic elements and imaging biomarkers. Hyperintense hepatocellular carcinoma (HCC) demonstrates lower malignancy and a generally good prognosis, but exhibits poorer response to immunotherapies, including anti-programmed cell death inhibitors. Heterogeneously hyperintense HCCs show poor treatment outcomes. Hepatocellular adenomas with β-catenin mutation exhibit HB phase hyperintensity with signal-intensity patterns capable of discriminating malignant transformation potentials based on exon 3 mutation. Focal nodular hyperplasia (FNH) and FNH-like lesions show HB phase hyperintensities with various signal-intensity patterns, significantly reducing unnecessary biopsies for diagnosis. Nodular regenerative hyperplasia and regenerative and multiacinar regenerative nodules also present hyperintensity or ring-like hyperintensity in the HB phase but no enhancement in the arterial phase. Cloud enhancement in intrahepatic cholangiocarcinoma serves as both a key differential diagnostic feature and a poor prognostic indicator. Liver metastases from colorectal, breast, and pancreatic adenocarcinomas occasionally contain mildly hyperintense areas that may correlate with a poor prognosis or lower chemotherapy response. Peritumoral hyperintensity can be identified in hypervascular lesions and relatively large tumors; however, its clinical significance has not yet been established. Understanding hyperintensity patterns in the HB phase aids in accurate imaging diagnosis and offers valuable prognostic and therapeutic biomarker information. This review explores the clinical significance, diagnostic implications, and prognostic value of hyperintense lesions on gadoxetic acid-enhanced MRI.
引用
- Ozaki K, Goshima S. Hyperintense liver lesions on hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance imaging: clinical insights and significance. Abdom Radiol (NY). 2025. PMID: 40824538. doi:10.1007/s00261-025-05169-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。